Al Yammahi is CEO of Hayat Biotech, a UAE-based biopharmaceutical company with a growing international footprint. He played a central role in establishing Hayat-Vax production in the UAE, the first COVID-19 vaccine manufactured in the MENA region, and in developing manufacturing facilities in Abu Dhabi and Serbia. Under his leadership, Hayat Biotech has expanded across healthcare solutions and technology transfer, building strategic partnerships, strengthening local capabilities and delivering humanitarian healthcare solutions to communities with limited access.